Streetbeat News

Revenues

DFH

Dream Finders Homes reported Q3 2024 earnings that missed estimates, with GAAP EPS at $0.70 versus the expected $0.84, and sales at $1.01 billion versus the expected $1.07 billion. Despite a 10% increase in homebuilding revenues and a 5% increase in home closings, the company's gross margin and net income decreased compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:18 am

LAUR

Laureate Education reported its Q3 2024 financial results, with GAAP EPS of $0.56 and sales of $368.6 million, both surpassing analyst estimates. The sales exceeded the expected $361.8 million.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:18 am

SXC

SunCoke Energy reported Q3 earnings per share of $0.36, significantly beating the analyst estimate of $0.22. Sales were $490.10 million, also surpassing the expected $409.95 million. Despite the earnings beat, sales decreased by 5.82% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:18 am

OTSKY

Otsuka Holdings reported a significant increase in Q3 earnings and sales, with EPS rising 36.84% to $0.52 and sales increasing 13.43% to $4.17 billion compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:15 am

UPBD

Upbound Group (NASDAQ:UPBD) reported Q3 2024 earnings of $0.95 per share, surpassing the analyst estimate of $0.93. The company's sales reached $1.069 billion, exceeding the expected $1.041 billion and marking a 9.18% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:14 am

OBE

Obsidian Energy reported Q3 2024 earnings of C$1.58 per share, surpassing the analyst estimate of C$1.06 by 49.06%. Sales increased to C$218.2M, up 8.88% YoY.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:13 am

MBUU

Malibu Boats anticipates a low single-digit year-over-year increase in net sales for FY25, with an adjusted EBITDA margin expected to range from 10% to 12%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:12 am

AME

AMETEK anticipates a mid-single-digit year-over-year sales growth for Q4 2024, with adjusted EPS expected to range between $1.81 and $1.86, reflecting an 8% to 11% increase from Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:11 am

COP

ConocoPhillips reported Q3 2024 earnings per share of $1.78, surpassing the analyst estimate of $1.64, but sales of $13.604 billion fell short of the $14.018 billion estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:11 am

TVTX

Travere Therapeutics reported Q3 2024 earnings with a GAAP EPS of $(0.70), meeting analyst expectations. The company achieved sales of $62.90 million, surpassing the $59.70 million estimate and marking a 69.56% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 11:11 am